Our vision is to defeat cancer and advance health equity for ALL communities through patient-centric social innovation and intentional, mission-aligned impact investing.
BrightEdge exists to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity
Learn how BrightEdge will help improve 1.5 million lives by investing in cancer-focused therapies and technologies in its most recent annual report and infographic.
The BrightEdge Entrepreneurs (BEE) program is the first cancer-focused, geography-agnostic, early-stage venture accelerator offering access to training, experts, resources & capital. This inaugural program is aimed at supporting and training emerging bioentrepreneurs to accelerate research discoveries for the benefit of patients.